Advertisement

Topics

Combating antiviral drug resistance with dynamic therapeutics

20:00 EDT 23 Aug 2017 | AAAS

(Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign) Christopher Brooke, assistant professor of microbiology at the University of Illinois and member of the Infection Genomics for One Health research theme at the Carl R. Woese Institute for Genomic Biology is part of a DARPA-funded program called INTERfering and Co-Evolving Prevention (INTERCEPT) which seeks to develop antiviral drugs that evolve along with viruses to combat resistance.

Original Article: Combating antiviral drug resistance with dynamic therapeutics

NEXT ARTICLE

More From BioPortfolio on "Combating antiviral drug resistance with dynamic therapeutics"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...